Engineered RBCs Encapsulating Antigen Induce Multi-Modal Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
Colin J. Raposo, Judith D. Cserny, Gloria Serena et al. · Frontiers in Immunology · 2022
Antigen-specific therapies that suppress autoreactive T cells without inducing systemic immunosuppression are a much-needed treatment for autoimmune diseases, yet effective strategies remain elusive. We describe a microfluidic Cell Squeeze® technology to engineer red blood cells (RBCs) encapsulating antigens to generate tolerizing antigen carriers (TACs). TACs exploit the natural route of RBC clearance enabling tolerogenic presentation of antigens. TAC treatment led to antigen-specific T cell tolerance towards exogenous and autoantigens in immunization and adoptive transfer mouse models of type 1 diabetes (T1D), respectively. Notably, in several accelerated models of T1D, TACs prevented hyperglycemia by blunting effector functions of pathogenic T cells, particularly in the pancreas. Mechanistically, TACs led to impaired trafficking of diabetogenic T cells to the pancreas, induced deletion of autoreactive CD8 T cells and expanded antigen specific Tregs that exerted bystander suppression. Our results highlight TACs as a novel approach for reinstating immune tolerance in CD4 and CD8 mediated autoimmune diseases.
Cited by 20 works. doi:10.3389/fimmu.2022.869669
Authors
- Colin J. Raposo
- Judith D. Cserny
- Gloria Serena
- Jonathan Chow
- Patricia Cho
- Hanyang Liu
- David Kotler
- Armon Sharei
- HOWARD H. BERNSTEIN
- Shinu A. John
References
- Regulatory T Cells and Immune Tolerance
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- Following a diabetogenic T cell from genesis through pathogenesis
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- Immunogenic and tolerogenic cell death
- Pancreatic islet-specific T-cell clones from nonobese diabetic mice.
- Regulatory T cells: how do they suppress immune responses?
- T-bet is required for optimal proinflammatory CD4+ T-cell trafficking
- A vector-free microfluidic platform for intracellular delivery